Therefore, in this study, FKN signaling antagonism seems to prevent neuronal-microglia crosstalk and subsequent microglia overactivation, resulting in a reduction of anti-inflammatory signaling, and progression of neuroinflammation seen during AD (Finneran and Nash, 2019). Here, CX3CL1 is linked to Alzheimer disease.